What's new in antiplatelet and anticoagulant therapy recommendations for unstable angina/non-ST-elevation myocardial infarction: 2012 focused update from the American College of Cardiology Foundation/American Heart Association task force on practice guidelines.
第一作者:
Nanette K,Wenger
第一单位:
Division of Cardiology, Emory University School of Medicine, Atlanta, GA 30303, USA. nwenger@emory.edu
作者:
主题词
腺苷(Adenosine);投药, 口服(Administration, Oral);心绞痛, 不稳定型(Angina, Unstable);抗凝药(Anticoagulants);循证医学(Evidence-Based Medicine);出血(Hemorrhage);人类(Humans);心肌梗死(Myocardial Infarction);哌嗪类(Piperazines);血小板聚集抑制剂(Platelet Aggregation Inhibitors);危险性评估(Risk Assessment);危险因素(Risk Factors);噻吩类(Thiophenes);治疗结果(Treatment Outcome);华法林(Warfarin)
DOI
10.1002/clc.22065
PMID
23070718
发布时间
2021-10-21
- 浏览6

Clinical cardiology
669-72页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文